|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| A61P 37/08 | (2006.01) |
| (11) | Number of the document | 2356151 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09744292.5 |
| Date of filing the European patent application | 2009-10-27 | |
| (97) | Date of publication of the European application | 2011-08-17 |
| (45) | Date of publication and mention of the grant of the patent | 2013-04-10 |
| (46) | Date of publication of the claims translation | 2013-08-26 |
| (86) | Number | PCT/US2009/062168 |
| Date | 2009-10-27 |
| (87) | Number | WO 2010/053751 |
| Date | 2010-05-14 |
| (30) | Number | Date | Country code |
| 260307 | 2008-10-29 | US |
| (72) |
MARTIN, Joel, H., US
HUANG, Tammy, T., US
FAIRHURST, Jeanette, L., US
PAPADOPOULOS, Nicholas, J., US
|
| (73) |
Regeneron Pharmaceuticals, Inc.,
777 Old Saw Mill River Road, Tarrytown, NY 10591,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Didelio afiniškumo žmogaus antikūnai prieš žmogaus IK-4 receptorius |
| HIGH AFFINITY HUMAN ANTIBODIES TO HUMAN IL-4 RECEPTOR |
| Payment date | Validity (years) | Amount | |
| 2025-09-23 | 17 | 347.00 EUR |
| 2026-10-27 |